The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The objective of this dose-ranging study is to determine the effects of several intravenous (IV) regimens of otamixaban on pharmacodynamic markers (including markers of thrombosis and coagulation markers), safety/tolerability, clinical efficacy and pharmacokinetics.
Epistemonikos ID: dc037bc96ec180b39366815dfedee244b6c60271
First added on: May 04, 2024